Key result
Pulmonary artery intimal sarcoma mimics pulmonary embolism and proves fatal despite chemotherapy.
Case Report (n=1)
No
Highlights the importance of considering pulmonary artery intimal sarcoma in patients with suspected pulmonary embolism who do not respond to anticoagulation therapy.
Consider pulmonary artery intimal sarcoma in anticoagulation-refractory suspected pulmonary embolism; single case leaves open prospective diagnostic validation.
The present case study reported on a patient initially diagnosed with pulmonary embolism at the First Affiliated Hospital of Fujian Medical University (Fuzhou, China) in May 2021. Furthermore, a relevant literature review was performed. The patient was a 57-year-old Chinese male who presented with dyspnea and wheezing following exercise. Physical examination revealed pulmonary valve second heart sound > aortic valve second heart sound but lack of swelling on both lower limbs, while the imaging results suggested pulmonary artery filling defects. Initially, the patient was diagnosed with pulmonary embolism and was administered anticoagulation treatment, which lasted for 3 months but proved to be ineffective. Subsequent re-examination via chest computed tomography further indicated multiple nodules in the left hilum and lung. Therefore, the patient was hospitalized for lung aspiration biopsy, which led to the final diagnosis of pulmonary artery intimal sarcoma based on the pathological review.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2022) conducted a case report in Pulmonary artery intimal sarcoma (n=1). Epirubicin and anlotinib was evaluated on Survival. A 57-year-old male initially misdiagnosed with pulmonary embolism was ultimately diagnosed with pulmonary artery intimal sarcoma and succumbed to the disease despite chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: